Navigation Links
As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage
Date:8/19/2010

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal... -- OXFORD, England, August 19, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Cosmetics and Personal Care, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage

 

OXFORD, England, August 19, 2010 /PRNewswire/ -- PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

The scope of PharmaDeals Agreements database has been expanded to include categories of deals that have medical and therapeutic applications in cosmetics, internet and e-commerce, nutritional supplements, packaging, wound care, bioterrorism, as well as deeper classifications within drug delivery technologies.

Fintan Walton, PhD, Chief Executive of PharmaVentures, says, "We are very excited about our latest version of PharmaDeals. One of the big issues that face those in researching and analysing deals is the lack of scope within databases they use which is a result of the huge changes taking place in the world of deal making. More companies are doing specialist deals, for example, with orphan drugs, and the world is changing as new technologies, mechanisms of action and even new therapy areas emerge. Frankly no one else has tried to come up with solutions to these changes."

New content is also being sourced related to deal making by Clinical Research and Contract Manufacturing Organizations. The development to the database augments recent improvements to the classifications and user interface.

As deal making is a people business subscribers can for the first time access exclusive television interviews with the key deal makers in the major pharmaceutical companies as well as key influencers at the corporate level such as CEOs and Board Members of corporations.

Dr Walton continues, "A key priority for us is to better serve our customers with information about deals from rapidly developing markets, and we have done this by considerably increasing our sources, especially in India, China, and generally within South Asia and South America. These developments to our content are additional key milestones for us, and, in the very near future, we shall be bringing news of further offerings to help our clients' ability to win the best deals for them."

Notes to Editors:

About PharmaVentures

PharmaVentures Limited (http://www.pharmaventures.com) is based in Oxford, England and is a leading international corporate advisory firm supporting its clients' growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and government bodies. It also produces the highly popular PharmaDeals(R) range of intelligence products including analysis tools and reports. In 2006, it launched the world's first dedicated online pharmaceutical television channel PharmaTelevision(R) ( http://www.pharmatelevision.com)

http://www.pharmaventures.com http://www.pharmadeals.net http://www.pharmatelevision.com PharmaDeals(R) is a registered Trade Mark of PharmaVentures Ltd.

For further information about PharmaDeals and other PharmaVentures products and services, including ordering, please contact:

Doug Cookson Commercial Director, PharmaVentures Magdalen Centre Oxford Science Park Oxfordshire OX4 4GA, UK T: +44(0)1865-332731 E: doug.cookson@pharmaventures.com
'/>"/>

SOURCE PharmaVentures
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
2. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
3. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
4. RedOak Logics Mission: Transform Pharmaceutical Industry Drug Development
5. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
6. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
7. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
8. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
9. Ferring Pharmaceuticals FIRMAGONĀ® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasiteā€™s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):